Author
@Dr_Crossroads Dr_Crossroads
grade Bx.com/Dr_Crossroads ↗
High-conviction long-only growth analyst on AI-infra, SaaS and fintech names
Posts fundamental theses, earnings reactions, and disclosed
trader score
+0.76
hit rate
35%
mean α
+0.93%
signals 14d
69
Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.
Their picks, scored
Across their last 20 scored bets: 35% hit rate, +0.93% mean alpha, trader score +0.76. Their last-14d mentions, direction-adjusted, have moved -10.1% since posting (mean over 61 mentions with price data).
Recent signals15receipts included
| date (PT) | ticker | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|---|
| 2026-10-16 | HOOD | @Dr_Crossroads | +0.10 | Cites Robinhood material showing retail investors are still buying. | -3.8% | tweet ↗ |
| 2026-10-16 | QQQ | @Dr_Crossroads | -0.65 | Reports the Nasdaq tracking toward its worst trading day of 2026. | -0.8% | tweet ↗ |
| 2026-10-16 | SPCX | @Dr_Crossroads | +0.55 | Argues a Tesla-SpaceX merger is nearly inevitable and sees the demonstration as evidence of synergy. | · | tweet ↗ |
| 2026-10-16 | TSLA | @Dr_Crossroads | +0.55 | Argues a Tesla-SpaceX merger is nearly inevitable and sees the demonstration as evidence of synergy. | +4.9% | tweet ↗ |
| 2026-10-15 | FIGR | @Dr_Crossroads | +0.65 | Calls $2.1 billion of recent securitization and whole-loan sales highly positive for Figure. | -16.2% | tweet ↗ |
| 2026-10-15 | FIGR | @Dr_Crossroads | +0.70 | Teases a bullish six-quarter Figure thesis focused on the current rate environment. | -16.2% | tweet ↗ |
| 2026-10-15 | FIGR | @Dr_Crossroads | +0.55 | Endorses Figure's growth, with supporting detail contained in linked media. | -16.2% | tweet ↗ |
| 2026-10-15 | FIGR | @Dr_Crossroads | +0.45 | Reports FIGR posting a double-digit gain. | -16.2% | tweet ↗ |
| 2026-10-15 | · | @Dr_Crossroads | · | Buy during fear and sell during greed. — States an explicit recurring contrarian market trading rule. | · | tweet ↗ |
| 2026-10-15 | CRWV | @Dr_Crossroads | -0.55 | Warns that financing constraints and likely convertible issuance could be unattractive for CRWV shareholders. | -22.2% | tweet ↗ |
| 2026-10-15 | FIGR | @Dr_Crossroads | +0.55 | Discloses a recent FIGR purchase and welcomes immediate accumulation in the stock. | -16.2% | tweet ↗ |
| 2026-10-15 | NU | @Dr_Crossroads | +0.30 | Bought FIGR, may add CRWV, and hopes to rebuild NU later. — Describes reallocating from NU into FIGR during fear and states an intention to add CRWV. | +2.9% | tweet ↗ |
| 2026-10-15 | FIGR | @Dr_Crossroads | +0.80 | Bought FIGR, may add CRWV, and hopes to rebuild NU later. — Describes reallocating from NU into FIGR during fear and states an intention to add CRWV. | -16.2% | tweet ↗ |
| 2026-10-15 | CRWV | @Dr_Crossroads | +0.45 | Bought FIGR, may add CRWV, and hopes to rebuild NU later. — Describes reallocating from NU into FIGR during fear and states an intention to add CRWV. | -22.2% | tweet ↗ |
| 2026-10-14 | RKLB | @Dr_Crossroads | +0.55 | Calls RKLB below $55 and VOYG at $25 attractive opportunities after the space-sector pullback. | -11.1% | tweet ↗ |
Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.